Trial · NCT02449044
Results by group207
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 207
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Participants With Adverse Events (AEs) | Tolvaptan | Participants with TEAEs | 105 | participants | |
| Participants With Adverse Events (AEs) | Tolvaptan | Participants with serious TEAEs | 76 | participants | |
| Participants With Adverse Events (AEs) | Tolvaptan | Participants with severe TEAEs | 73 | participants | |
| Participants With Adverse Events (AEs) | Tolvaptan | Participants discontinued IMP due to TEAE | 19 | participants | |
| Participants With Adverse Events (AEs) | Tolvaptan | Participants discontinued IMP due to TEAE/death | 28 | participants | |
| Participants With Adverse Events (AEs) | Tolvaptan | Deaths | 19 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Blood creatinine increased | 4 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Blood potassium increased | 4 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Blood glucose increased | 3 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Blood potassium decreased | 3 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | SerumChemistry-Aspartate aminotransferaseincreased | 2 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Blood cholesterol increased | 3 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Blood sodium increased | 2 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Hepatic enzyme increased | 2 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Oxygen saturation decreased | 2 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Hyperglycaemia | 5 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Hyperkalaemia | 7 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Hyperlipidaemia | 4 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Hypernatraemia | 4 | participants | |
| Participants With Laboratory Values Abnormalities Reported as TEAEs | Tolvaptan | Serum Chemistry-Hyperuricaemia | 3 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02449044/results